Astrazeneca PLC Director of Business Development Salaries in Boulder
The average Astrazeneca PLC Director of Business Development in Boulder earns an estimated $216,212 annually, which includes an estimated base salary of $166,464 with a $49,747 bonus. Astrazeneca PLC's Director of Business Development compensation is $49,910 more than the US average for a Director of Business Development. Director of Business Development salaries at Astrazeneca PLC in Boulder can range from $73,000 - $390,000.
In Boulder, The Business Development Department at Astrazeneca PLC earns $1,457 more on average than the Product Department.
Last updated a year ago.
- $166,464
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at Astrazeneca PLC
In Boulder, Directors of Business Development earn $3,877 more than Directors of Business Development.
Compensation at Astrazeneca PLC by Department
In Boulder, The Business Development Department averages $1,457 more than the Product Department, and $35,094 less than the Communications Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Astrazeneca PLC reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Astrazeneca PLC reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Astrazeneca PLC Rate Their Compensation
The majority of Directors of Business Development at Astrazeneca PLC believe they're compensated fairly. 100% of Directors of Business Development at Astrazeneca PLC say they receive annual bonuses, and the vast majority (74%) are satisfied with their benefits. See more compensation ratings at Astrazeneca PLC
